Beta-Haemolytic Group A, C and G Streptococcal Infections in Southern Hungary: A 10-Year Population-Based Retrospective Survey (2008-2017) and a Review of the Literature
Overview
Affiliations
Introduction: Pyogenic β-hemolytic streptococci (including Group A, C and G ) are some of the most important Gram-positive bacterial pathogens in human medicine. Although effective therapy is available, invasive streptococcal infections are associated with a significant disease burden.
Methods: In this retrospective study, the epidemiological characteristics of invasive Group A (iGAS) and Group C and G (iGCGS) streptococci, along with tonsillo-pharyngitis-causing pGAS and pGCGS infections, were assessed in Southern Hungary. A total of 1554 cases of streptococcal tonsillo-pharyngitis infections (26.5-44.1/100,000 persons, pGAS: 95.5%; n=1484) and 1104 cases of invasive streptococcal infections were detected (12.5-31.4/100,000 persons, iGAS: 77.9%; n=861).
Results: The average age of the affected patients in the various groups were the following: pGAS: 13.2±13.1 years, pGCGS: 21.0±15.0 years (p=0.039), iGAS: 49.1±12.8 years, iGCGS: 58.7±18.5 years (p>0.05). iGAS isolates originated from abscesses (47.1%), blood culture samples (24.1%), surgical samples (16.7%), biopsies (4.6%), pleural fluid (3.5%), pus (2.0%), synovial fluid (1.3%) and cerebrospinal fluid samples (0.7%). In contrast, iGCGS isolates mainly originated from blood culture samples (53.8%), abscesses (22.9%), surgical samples (12.3%), synovial fluid (5.1%), pleural fluid (3.7%), pus (1.8%) and cerebrospinal fluid samples (0.4%). All respective isolates were susceptible to benzyl-penicillin; overall resistance levels for erythromycin (10.5% for GAS, 21.4% for GCGS) and clindamycin (9.2% for GAS, 17.2% for GCGS) were significantly higher in GCGS isolates, while resistance levels for norfloxacin were higher in GAS isolates (13.5% for GAS, 6.9% for GCGS).
Conclusion: The rates of resistance to macrolides and clindamycin are a cause for concern (especially among GCGS isolates); however, resistance levels are still relatively low, compared to Southern European countries.
Leli C, Bottino P, Ferrara L, Pizzo V, Canepari M, Ciriello M Infez Med. 2025; 33(1):90-97.
PMID: 40071254 PMC: 11892445. DOI: 10.53854/liim-3301-8.
The burden of group A (GAS) infections: The challenge continues in the twenty-first century.
Thacharodi A, Hassan S, Vithlani A, Ahmed T, Kavish S, Geli Blacknell N iScience. 2025; 28(1):111677.
PMID: 39877071 PMC: 11773489. DOI: 10.1016/j.isci.2024.111677.
Biala M, Babicki M, Malchrzak W, Janiak S, Gajowiak D, Zak A Pathogens. 2024; 13(10).
PMID: 39452718 PMC: 11510161. DOI: 10.3390/pathogens13100846.
Adamkova V, Adamkova V, Kroneislova G, Zavora J, Kroneislova M, Huptych M Microorganisms. 2024; 12(5).
PMID: 38792824 PMC: 11124258. DOI: 10.3390/microorganisms12050995.
A Review of the Impact of Streptococcal Infections and Antimicrobial Resistance on Human Health.
Gergova R, Boyanov V, Muhtarova A, Alexandrova A Antibiotics (Basel). 2024; 13(4).
PMID: 38667036 PMC: 11047474. DOI: 10.3390/antibiotics13040360.